InvestorsHub Logo
Followers 9
Posts 846
Boards Moderated 0
Alias Born 05/22/2013

Re: None

Tuesday, 06/12/2018 12:41:20 PM

Tuesday, June 12, 2018 12:41:20 PM

Post# of 52207
HMNY: AMAZON, NETFLIX, OR MICROSOFT, A MOVIEPASS BUY VERY POSSIBLE, $20 PRICE TARGET, A WIN-WIN, JUNE 11, 2018














ANALYSTS ARE NOW BULLISH ON THE STOCK AS DISTRIBUTING FILMS WITH NEW PRODUCTIONS SHOULD BE A WIN-WIN.

A POTENTIAL BUY IS VERY POSSIBLE FOR MOVIEPASS BY AMAZON(AMZN), NETFLIX (NFLX) OR MICROSOFT (MSFT) .

CWEB ANALYSTS HAVE ISSUED A BUY RATING FOR HELIOS AND MATHESON ANALYTICS (HMNY) AND A PRICE TARGET OF $20


JUNE 11, 2018 BY CWEB

WILL NETFLIX, AMAZON OR MICROSOFT BUY MOVIEPASS – CWEB.COM

BY LESLIE COHEN

MICROSOFT (MSFT ) JUST PAID $7.5 BILLION FOR GITHUB A SUBSCRIPTION SOFTWARE CO. GITHUB HAS ABOUT THE SAME NUMBER OF SUBSCRIBERS AS MOVIEPASS ABOUT 3 MILLION
and charge between $9- $20/ month. MOVIEPASS GROWING WAY FASTER THEN GITHUB did, GITHUB HAS 800 EMPLOYEES TO MOVIEPASS 70 EMPLOYEES, GitHub employees are expensive compared to MoviePass.

ON JANUARY 19, 2018 AT THE SUNDANCE FILM FESTIVAL, MOVIEPASS ANNOUNCED THE NEW SUBSIDIARY MOVIEPASS VENTURES, which will co-acquire films with traditional distributors. Lowe explained that the company wanted to “bring great films to the big screen across the country for our subscribers”, and that “GIVEN THE SUCCESSES WE HAVE DEMONSTRATED FOR OUR DISTRIBUTOR PARTNERS IN ENSURING STRONG BOX OFFICE IN THE THEATRICAL WINDOW, IT’S ONLY NATURAL FOR US TO DOUBLE DOWN AND WANT TO PLAY ALONGSIDE THEM – AND SHARE IN THE UPSIDE.”MoviePass Ventures’ first acquisition (in partnership with The Orchard), Bart Layton’s American Animals, will be released on June 1, 2018.

IN JUNE 2016, MOVIEPASS NAMED MITCH LOWE, A FORMER EXECUTIVE OF NETFLIX (NFLX) AND REDBOX, AS ITS NEW CEO. Lowe had been an advisor to the company since 2014. Under Lowe, the service began to experiment with different pricing models
Helios advanced MoviePass $55 million from December to February 20, 2018. MoviePass then converted the advances from debt to capital. Helios thus ownership stake increased from 62.4 percent to 81.2 percent. Another $35 million in advances converted to capital put Helios to 91.8 percent allowing for a merger unilateral initiated by the Helios board.


In February 2018, the price further dropped to $7.95 per month for new customers if they paid annually.
IN APRIL 2018, HELIOS AND MATHESON ACQUIRED THE MOVIE LISTINGS WEBSITE MOVIEFONE FROM VERIZON’S (VZ) digital media subsidiary Oath Inc. As part of the transaction, Verizon took a stake in MoviePass stock
Helios and Matheson Analytics (HMNY) provide information technology services and solutions that focus on big data, artificial intelligence, business intelligence, social listening, and consumer-centric technology. Helios currently owns approximately 92% of the outstanding shares (excluding options and warrants) of MoviePass Inc. Helios also represents companies in the healthcare, retail, education, and government industries.

Helios stock (HMNY) has progressed back 15% since Citadel Securities increasing its stake by 5.4% to 6% led to a short lived rally of the stock Helios and Matheson Analytics Inc. (NASDAQ:HMNY) which has year to date performance of -94.31%. Panic selling set in when investors talked about the rate of cash burn the company is going through. The stock now trades at $.034 from its $32.9 high a year ago today.
MoviePass will take over the library of Emmet Furla Oasis (NYSEARCA:EFO) films, the studio responsible for the Rambo films and Lone Survivor.HMNY will have a 51% of the new company, and EFO will own a 49% minority stake. The new company will be called MoviePass Films.

BULLISH ON THE STOCK AS DISTRIBUTING FILMS WITH NEW PRODUCTIONS SHOULD BE A WIN-WIN. EFO films founder said in a statement, “What impresses me the most is that MoviePass can guarantee box office attendance, which is a game changer. I don’t believe anybody else can do that.”

MOVIEPASS HAD A GROWTH SUBSCRIBER RATE OF 15000% IN 10 MONTHS ,GAINING 3 MILLION SUBSCRIBERS
from 20,000 subscribers. Helios plans to capitalize on the unique assets of its subsidiary, MoviePass Inc. (“MOVIEPASS”), TO MARKET FUTURE MOVIEPASS FILMS TO THE MILLIONS OF MOVIEPASS SUBSCRIBERS AND MOVIEGOERS ALL OVER THE WORLD.

MOVIEPASS INC. IS A MARKETING PLATFORM ENHANCING IS THE NATION’S PREMIER MOVIE-THEATER SUBSCRIPTION SERVICE, MoviePass provides film lovers the ability to see up to one new movie title per day in theaters. MoviePass is accepted at over 90% of theaters across the United States.

INSTITUTIONAL OWNERSHIP TRENDS SUGGEST THAT THE STOCK IS CHEAP and the insider trading data indicates that INSIDERS ARE BULLISH.

TECHNICAL INDICATORS ALSO SUGGEST THAT HELIOS AND MATHESON ANALYTICS (HMNY) , IS UNDERVALUED.

A POTENTIAL BUY IS VERY POSSIBLE FOR MOVIEPASS BY AMAZON(AMZN), NETFLIX (NFLX) OR MICROSOFT (MSFT) .

CWEB ANALYSTS HAVE ISSUED A BUY RATING FOR HELIOS AND MATHESON ANALYTICS (HMNY) AND A PRICE TARGET OF $20

HMNY data by YCharts



Source:

https://cweb.com/will-netflix-amazon-or-microsoft-buy-moviepass/







SEE BELOW
IF YOU MISSED IT





HMNY:...A SHORT SQUEEZE IN SHARES, INSTITUTIONAL INVESTORS OWN 83.21% OF THE OUTSTANDING SHARE



OVER 4,700 ANALYSTS, HMNY FLOATS A MODERATE BUY RATING AT THE MOMENT.

WALL STREET ANALYSTS POLLED IN THE LAST 3 MONTHS,

...A $12 PRICE TARGET FOR THE STOCK,

...A MORE THAN 3,400% UPSIDE FROM THE CURRENT PRICE.


ANALYSTS’ MEAN RECOMMENDATION FOR THE STOCK IS 1.50__ (A RATING OF LESS THAN 2 MEANS BUY,

A GAME CHANGER. I DON’T BELIEVE ANYBODY ELSE CAN DO THAT.”




83.21% OF THE OUTSTANDING SHARE SUPPLY IS HELD BY INSTITUTIONAL INVESTORS

LIKELIHOOD OF A SHORT SQUEEZE IN SHARES OF HMNY.





WHAT IS A 'SHORT SQUEEZE'

A short squeeze is a situation in which a heavily shorted stock or commodity moves sharply higher, forcing more short sellers to close out their short positions

SHORT SQUEEZE - INVESTOPEDIA

Source:

https://www.investopedia.com/terms/s/shortsqueeze.asp









• COMPANY
THIS STOCK CAN PROVE ITS WORTH: HELIOS AND MATHESON ANALYTICS INC. (HMNY)

BY

ULYSSES ERICKSON
-
JUNE 11, 2018

Helios and Matheson Analytics Inc. (NASDAQ:HMNY) subtracted -$0.01 to its price during the regular trading session on Friday, reaching $0.36. When it comes to volume, 21.49 million shares of this company’s common stock changed hands. Helios and Matheson Analytics Inc. (NASDAQ:HMNY) has experienced a 1-year low price of $0.33 and a 1-year high price of $38.86. This organization’s current debt-to-equity ratio is , its current ratio is 0.40 and its quick ratio is 0.40 at the time of writing. The company has a beta of 1.68.

MAXIM GROUP REITERATED SHARES OF HELIOS AND MATHESON ANALYTICS INC. (NASDAQ:HMNY) TO A BUY RATING IN A REPORT POSTED ON WEDNESDAY, FEBRUARY 28TH, 2018. AT THE PRESENT, THEY HAVE A PRICE TARGET FOR THE INFORMATION TECHNOLOGY SERVICES SET AT $16.

Several additional equities analysts have also published recent reports on HMNY stock. Canaccord Genuity, for example, Initiated Helios and Matheson Analytics Inc. to Buy in a report that was made public on Thursday, February 22nd, 2018. MAXIM GROUP REITERATED A $25 PRICE TARGET ON HELIOS AND MATHESON ANALYTICS INC. IN A REPORT FROM MONDAY, NOVEMBER 6TH, 2017, while giving the stock to a Buy rating. In a report sent out on Monday, October 2nd, 2017, Maxim Group Initiated the stock rating on Helios and Matheson Analytics Inc. to a Buy. In total, 0 Wall Street analysts have given this stock a hold rating, with 2 analysts rating it as a strong buy. AT THE TIME OF WRITING, THIS STOCK HAS A CONSENSUS PRICE TARGET SET AT $9.67 AND AVERAGE ANALYST RATING SET TO STRONG BUY.

There is a technical analysis indicator called the Relative Strength Index, or RSI, and analysts use it to measure momentum within a range of 0 to 100. When a stock’s RSI falls under 30, it is considered to be oversold. For Helios and Matheson Analytics Inc., specifically, the RSI metric has reached 26.15 . Helios and Matheson Analytics Inc. (NASDAQ:HMNY) has lost -92.06% in value over the last three months, and -95.36% over the last six-month period. Over the last full year, the stock price has lost -86.14%.

The measurement of a stock’s predictable daily price range is referred to as volatility – and it’s also the price range within which a day trader does his or her business. Higher volatility translates to higher losses or profits. After recently verifying the number, Helios and Matheson Analytics Inc. (NASDAQ:HMNY) stock has a volatility measurement of 14.29% for the week, with 16.99% volatility as observed from the past 30 days. The public company has 78.55M shares outstanding currently, as well as a market cap of $28.20M. This stock’s distance from its 20-day simple moving average is -30.96%, based on a recent bid, while its distance from the 50-day simple moving average is currently -79.99%. Meanwhile, it has a distance of -94.72% from the 200-day simple moving average. Today, this organization is sitting -99.08% away from its 52-week high price and 8.20% away from its 52-week low price.

More detail-oriented stock traders might be keeping tabs on another metric: the Williams Percent Range or Williams %R. The Williams %R measurement is a widely-used technical indicator founded by Larry Williams to enable the identification of oversold and overbought stock territory. Traders will typically use Williams %R alongside other trend indicators to help locate potential turning points in a stock’s price trajectory. Helios and Matheson Analytics Inc. (NASDAQ:HMNY)’s Williams Percent Range, or 14-day Williams %R, is sitting at 93.26 at the time of writing. Generally speaking, if the indicator rises above -20, the shares may be overbought. On the flip side, if the indicator goes below -80, it may mean that the stock has crossed over into oversold territory.
Investors oftentimes keep their eyes on the latest stock price support and resistance levels. The support is a lower “floor” level where a stock may bounce back after it has dipped. IF THE SHARE PRICE CAN PENETRATE THE FIRST SUPPORT LEVEL, INVESTOR ATTENTION MAY SHIFT TO THE SECOND LEVEL. The resistance is the contrary of support levels. As a stock grows in value, it may see a dip once it reaches a specific level of resistance. After a recent examination, this company’s shares’ first resistance level is sitting at 0.39. Meanwhile, investors are looking out for the first support level, which is 0.34.

Source:

fintelegraph.com/2018/06/11/this-stock-can-prove-its-worth-helios-and-matheson-analytics-inc-hmny/








Helios and Matheson (HMNY) Keeps Investors at the Edge of Their Seats
Partner Content

BY TIPRANKS | JUNE 11, 2018 — 7:58 AM EDT

ADD TO WATCHLIST
HMNY
Helios and Matheson Analytics Inc
0.38

+4.57%
View Watchlist
MoviePass, a concept that has turned the moviegoer experience into a monthly subscription, has been in the news lately. MoviePass owner Helios and Matheson Analytics, Inc. (NASDAQ:HMNY) has kept investors glued to their desktops, as the stock has had a volatile run lately, owing to a multitude of factors.

Although the revolutionary concept did not gain a lot of traction in the beginning, a massive cut in the subscription cost suddenly led to a boost in subscribers. What started in 2011 with around 20,000 subscribers, saw a splurge in the subscriber count to over 2.5 million when the company announced they are cutting down the rental to $9.95, offering 30 movie tickets a month for the price of one.

Coming to the factors that have led to a see-sawing performance in the stock, the company’s announcement that it is burning around $21.7 million cash a month led to panic selling. Although Citadel Securities’ announcement that it upped its stake in HMNY by 5.4% led to a 6% rally in the stock, the joy was short-lived. Helios has declined around 15% from the high it reached following Citadel’s announcement, as the cash burn remains the primary talking point for investors.

As a result, the stock is down to a record low of $0.34 from $32.9 in October last year. Among the latest drivers, MoviePass is slated to take over the film library and production slate of Emmet Furla Oasis (EFO) films, the studio behind films such as "Rambo" and "Lone Survivor." Under the deal terms, HMNY is set to own 51% of the new company with EFO owning a 49% minority stake, as the company aims to launch a new film division, MoviePass Films. Although the specific deal terms were not discussed, Randall Emmet and George Furla, founders of EFO, will be receiving a combination of cash and stock.

MoviePass CEO Mitch Lowe’s VISION TO LEVERAGE HIS STRONG SUBSCRIBER BASE TO INCREASE THE BOX OFFICE COLLECTION FOR HIS OWN FILMS IS A STEP CLOSER to reality with the latest acquisition. "To have such a well-known, quality production company join forces with the Helios/MoviePass group of companies at this early stage in our development is truly remarkable,” said Mitch Lowe in a statement.

MoviePass strives to profit by distributing the movies coupled with new productions. EFO films founder cheered the engagement, stating, “What impresses me the most is that MoviePass can guarantee box office attendance, which is A GAME CHANGER. I DON’T BELIEVE ANYBODY ELSE CAN DO THAT.”
Moreover, the ANALYST SENTIMENT AT THE STREET REMAINS BULLISH. Based on TipRanks, A WEBSITE THAT COMPILES RATINGS FROM OVER 4,700 ANALYSTS, HMNY FLOATS A MODERATE BUY RATING AT THE MOMENT. BOTH WALL STREET ANALYSTS POLLED IN THE LAST 3 MONTHS, HAVE A $12 PRICE TARGET FOR THE STOCK, REPRESENTING A MORE THAN 3,400% UPSIDE FROM THE CURRENT PRICE.


Following the 10-Q filing last month, Maxim analyst Nehal Chokshi upped his bullish sentiment for the stock, citing survey results by NRG and positive fundamentals. “[HMNY] achieved $1.4M from studio marketing & other vs. our estimate of $0.6M and our long-term steady state run rate of ~$32M/Q, Chokshi said. He added, survey data from 1,500 moviegoers conducted by NRG that is indicative that MoviePass is creating value for studios and exhibitors that ultimately should lead to MOVIEPASS CREATING A SUSTAINABLE BUSINESS.”

Source:

https://www.investopedia.com/investing/helios-and-matheson-hmny-keeps-investors-edge-their-seats/?partner=YahooSA&yptr=yahoo






Home Global Helios and Matheson Analytics Inc. (HMNY): What’s the Story?
• Global
Helios and Matheson Analytics Inc. (HMNY): What’s the Story?
By
Jerome Gibson
-
June 11, 2018
Helios and Matheson Analytics Inc. (HMNY) is an interesting player in the Technology space, with a focus on Information Technology Services. The stock has been active on the tape, currently trading at $0.36, down from yesterday’s close by -3.18%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.
Fundamental Analysis
Helios and Matheson Analytics Inc. (HMNY) currently trades with a market capitalization of $28.20 Million. That value represents a market adjusting for revenues that have been growing by 3,540.70 % on a quarterly year/year basis as of the company’s last quarterly report.
You can get a sense of how sustainable that is by a levered free cash flow of -$93.55 Million over the past twelve months. Generally speaking, earnings are expected to grow in coming quarters. Analysts are forecasting earnings of -$0.95 on a per share basis this quarter. Perhaps, that suggests something about why 83.21% OF THE OUTSTANDING SHARE SUPPLY IS HELD BY INSTITUTIONAL INVESTORS.


Technical Analysis

It’s important to check the technicals to get a sense of how HMNY has been acting. Looking at the stock’s movement on the chart, Helios and Matheson Analytics Inc. recorded a 52-week high of $38.86. It is now trading 38.5% off that level. The stock is trading $1.74 its 50-day moving average by 1.38%. The stock carved out a 52-week low down at $0.33.

In recent action, Helios and Matheson Analytics Inc. (HMNY) has made a move of -41.34% over the past month, which has come on weak relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 14.04, and it’s gotten there by action that has been more volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 31.16% with $72.78 Million sitting short, betting on future declines. That suggests something of THE LIKELIHOOD OF A SHORT SQUEEZE IN SHARES OF HMNY.

Source:

https://stocknewsjournal.com/2018/06/11/helios-and-matheson-analytics-inc-hmny-whats-the-story-7/






Technology
Is The Stock A Good Investment? – Helios and Matheson Analytics Inc. (NASDAQ:HMNY)
JUNE 11, 2018 NASDAQ JOURNAL STAFF 0 COMMENTS HELIOS AND MATHESON ANALYTICS INC., HMNY, NASDAQ:HMNY

Shares of Helios and Matheson Analytics Inc. (NASDAQ:HMNY) closed the previous trading session at $0.36, experiencing a change of -3.18% with 21,492,679 shares trading hands. The stock holds an average trading capacity of 13.71M shares for the past three months. When we compare its current volume with average for the same time of day, a Relative Volume (usually displayed as ratio) of 1.57 is obtained. It is kind of a like a radar for how “in-play” a stock is. The higher the relative volume is the more in play it is because more traders are watching and trading it. This is something that Investors should look for in all the stocks they are trading and is an important indicator to keep tabs on.

Is The Stock Safe to Invest? (Market Capitalization Analysis):
Now investors want to know the actual market worth of the company in the Stock Market. Market worth or Market capitalization is calculated by multiplying the price of a stock by its total number of outstanding shares. As a company has 81.88M shares outstanding and its current share price is $0.36, the market cap is $29.39M. From a safety point of view, a company’s size and market value do matter. All things being equal, large cap stocks are considered safer than small cap stocks. However, SMALL CAP STOCKS HAVE GREATER POTENTIAL FOR GROWTH.
Although market capitalization is key to consider, don’t invest (or not invest) based solely on it. It’s just one measure of value. As a serious shareholder, you need to look at plentiful factors that can assist you determine whether any given stock is a good investment.

Is The Stock A Good Investment? (P/E Analysis):

Price-earnings ratio, also known as P/E ratio, is a tool that is used by shareholders to help decide whether they should buy a stock. Basically, the P/E ratio tells potential shareholders how much they have to pay for every $1 of earnings. The formula for calculating the price-earnings ratio for any stock is simple: the market value per share divided by the earnings per share (EPS). This is represented as the equation (P/EPS), where P is the market price and EPS is the earnings per share. As the current market price of the stock is $0.36 and diluted EPS for the trailing twelve month is -13.11, the P/E ratio for the stock comes out as N/A.

Generally, shareholders love stocks with a low price-to-earnings (P/E) ratio. The perception is that the lower the P/E, the higher will be the value of the stock. The simple logic that a stock’s current market price does not justify (is not equivalent to) its higher earnings and therefore has room to run is behind shareholders’ inclination toward low P/E stocks.

Price/Earnings to Growth – PEG Ratio Analysis:

The price/earnings to growth ratio (PEG ratio) is a stock’s price-to-earnings (P/E) ratio divided by the growth rate of its earnings for a specified time period. For now, the company has PEG ratio of N/A. The PEG ratio is used to determine a stock’s value while taking the company’s earnings growth into account, and is considered to provide a more complete picture than the P/E ratio.

Despite the fact that a low P/E ratio may make a stock look like a good buy, factoring in the company’s growth rate to get the stock’s PEG ratio can tell a different story. The lower the PEG ratio, the more the stock may be undervalued given its earnings performance. The degree to which a PEG ratio value indicates an over or underpriced stock varies by industry and by company type; though a broad rule of thumb is that a PEG ratio below one is desirable. Also, the accuracy of the PEG ratio depends on the inputs used. Using historical growth rates, for example, may provide an inaccurate PEG ratio if future growth rates are predictable to deviate from historical growth rates. To distinguish between calculation methods using future growth and historical growth, the terms “forward PEG” and “trailing PEG” are sometimes used.

Stock’s Liquidity Analysis:
Presently, 6.70% shares of Helios and Matheson Analytics Inc. (NASDAQ:HMNY) are owned by insiders with 0.00% six-month change in the insider ownership. The insider filler data counts the number of monthly positions over 3 month and 12 month time spans. Short-term as well long term shareholders always focus on the liquidity of the stocks so for that concern, liquidity measure in recent quarter results of the company was recorded 0.40 as current ratio and on the opponent side the debt to equity ratio was N/A and long-term debt to equity ratio also remained N/A.

Brief Overview on Stock’s Performances:

The stock showed weekly performance of -17.57%, which was maintained for the month at -54.28%. Likewise, the performance for the quarter was recorded as -92.06% and for the year was -86.14%. ANALYSTS’ MEAN RECOMMENDATION FOR THE STOCK IS 1.50 (A RATING OF LESS THAN 2 MEANS BUY, “hold” within the 3 range, “sell” within the 4 range, and “strong sell” within the 5 range).

Disclaimer: Any news, report, research and analysis published on Nasdaqjournal.com are only for information purposes. Nasdaq Journal (NJ) makes sure to keep the information up to date and correct, but we didn’t suggest or recommend buying or selling of any financial instrument, unless that information is subsequently confirmed on your own. Information in this release is fact checked and produced by competent editors of Nasdaq Journal; however, human error can exist.

Source:

nasdaqjournal.com/2018/06/11/is-the-stock-a-good-investment-helios-and-matheson-analytics-inc-nasdaqhmny/15/10/46/